Literature DB >> 8693450

New prognostic factors in resectable non-small cell lung cancer.

E F Smit1, H J Groen, T A Splinter, T Ebels, P E Postmus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8693450      PMCID： PMC1090499          DOI： 10.1136/thx.51.6.638

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  81 in total

1.  Relation of neovascularisation to metastasis of non-small-cell lung cancer.

Authors:  P Macchiarini; G Fontanini; M J Hardin; F Squartini; C A Angeletti
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

2.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.

Authors:  G Sozzi; M Miozzo; R Donghi; S Pilotti; C T Cariani; U Pastorino; G Della Porta; M A Pierotti
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

Review 3.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

4.  Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study.

Authors:  A Niiranen; S Niitamo-Korhonen; M Kouri; A Assendelft; K Mattson; S Pyrhönen
Journal:  J Clin Oncol       Date:  1992-12       Impact factor: 44.544

5.  Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.

Authors:  F Lindemann; G Schlimok; P Dirschedl; J Witte; G Riethmüller
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

6.  Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer.

Authors:  A E Filderman; G A Silvestri; C Gatsonis; D J Luthringer; J Honig; S D Flynn
Journal:  Am Rev Respir Dis       Date:  1992-09

7.  Survival after resection of stage II non-small cell lung cancer.

Authors:  N Martini; M E Burt; M S Bains; P M McCormack; V W Rusch; R J Ginsberg
Journal:  Ann Thorac Surg       Date:  1992-09       Impact factor: 4.330

8.  Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.

Authors:  D C Quinlan; A G Davidson; C L Summers; H E Warden; H M Doshi
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

9.  Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.

Authors:  Y Horio; T Takahashi; T Kuroishi; K Hibi; M Suyama; T Niimi; K Shimokata; K Yamakawa; Y Nakamura; R Ueda
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

10.  Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.

Authors:  M Miyake; T Taki; S Hitomi; S Hakomori
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245
View more
  2 in total

Review 1.  Genetics and pulmonary medicine. 7. Somatic mutations in the development of lung cancer.

Authors:  M Roland; R M Rudd
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

Authors:  William B Armstrong; Thomas H Taylor; Ann R Kennedy; Raymond J Melrose; Diana V Messadi; Mai Gu; Anh D Le; Marjorie Perloff; Francisco Civantos; William Jarrard Goodwin; Lori J Wirth; Alexander Ross Kerr; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.